Yabao Pharmaceutical Group Co. Ltd. (600351)
Market Closed
11 Aug, 06:57
SSE SSE Primary ¥
6. 91
-0.05
-0.7184%
¥
4.32B Market Cap
- P/E Ratio
0.6% Div Yield
30.9M Volume
- Eps
¥ 6.96
Previous Close Want to track 600351 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | 0.02 |
| | | - | 0.09 |
| | | - | 0.02 |
| | | - | 0.09 |
| | | - | 0.11 |
| | | - | 0.1 |
| | | - | 0.04 |
| | | - | 0.07 |
| | | - | 0.07 |
| | | - | 0.07 |
| | | - | 0.02 |
| | | - | 0.06 |
| | | - | 0.05 |
| | | - | 0.05 |
| | | - | 0.08 |
600351 Earnings Reports FAQ
What is the earnings per share (EPS) for 600351?
EPS data for 600351 is currently not available, as Yabao Pharmaceutical Group Co. Ltd has not reported recent earnings.
What is the company's earnings growth rate?
Over the past 11 years, the earnings growth rate has been approximately -32.66%, reflecting the 600351's performance and SSE market conditions.
When is the next earnings release date?
Yabao Pharmaceutical Group Co. Ltd has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Yabao Pharmaceutical Group Co. Ltd are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 600351 at this time, as Yabao Pharmaceutical Group Co. Ltd has no recent EPS data to calculate it.
